Definitive Contract HT942523C0072

This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Real-Time Analyzers Inc., a small business that specializes in compact and portable NIR and Raman spectrometers. The $1,299,212.29 firm-fixed-price contract is for the development of an at-home saliva test for the immunosuppressant drug tacrolimus, referred to as the "Tacrolimus At-home Saliva Test (TAST)." This effort is part of the DHA's sequential Phase II SBIR program, which provides additional funding to further advance promising Phase I research and prototype solutions. The contract has a total small business set-aside designation, indicating Real-Time Analyzers is the prime contractor with no major subcontractors identified. This award builds on Real-Time Analyzers' prior experience delivering chemical detection and analysis solutions to the Department of Defense through the SBIR program.